Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case–Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort
Author(s) -
Mireia ObónSantacana,
Leila LujánBarroso,
Ruth C. Travis,
Heinz Freisling,
Pietro Ferrari,
Gianluca Severi,
Laura Baglietto,
MarieChristine BoutronRuault,
Renée T. Fortner,
Jennifer Ose,
Heiner Boeing,
Virginia Menéndez,
Emilio SánchezCantalejo,
Saioa Chamosa,
José María Huerta,
Eva Ardanáz,
KayTee Khaw,
Nicholas J. Wareham,
Melissa A. Merritt,
Marc J. Gunter,
Antonia Trichopoulou,
EleniMaria Papatesta,
Eleni Klinaki,
Calogero Saieva,
Giovanna Tagliabue,
Rosario Tumino,
Carlotta Sacerdote,
Amalia Mattiello,
H. B. Bueno-de-Mesquita,
Petra H. Peeters,
N. Charlotte OnlandMoret,
Annika Idahl,
Eva Lundin,
Elisabete Weiderpass,
Hubert W. Vesper,
Elio Ríboli,
Eric J. Duell
Publication year - 2015
Publication title -
cancer epidemiology biomarkers and prevention
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.234
H-Index - 192
eISSN - 1538-7755
pISSN - 1055-9965
DOI - 10.1158/1055-9965.epi-15-0822
Subject(s) - nested case control study , medicine , serous fluid , acrylamide , cohort study , european prospective investigation into cancer and nutrition , case control study , epidemiology , oncology , gynecology , chemistry , organic chemistry , copolymer , polymer
Acrylamide was classified as "probably carcinogenic to humans (group 2A)" by the International Agency for Research on Cancer. Epithelial ovarian cancer (EOC) is the fourth cause of cancer mortality in women. Five epidemiological studies have evaluated the association between EOC risk and dietary acrylamide intake assessed using food frequency questionnaires, and one nested case-control study evaluated hemoglobin adducts of acrylamide (HbAA) and its metabolite glycidamide (HbGA) and EOC risk; the results of these studies were inconsistent.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom